Mitsuhiko Abe

1.2k total citations
30 papers, 905 citations indexed

About

Mitsuhiko Abe is a scholar working on Hepatology, Molecular Biology and Epidemiology. According to data from OpenAlex, Mitsuhiko Abe has authored 30 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 13 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Mitsuhiko Abe's work include Cancer, Hypoxia, and Metabolism (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Cancer Cells and Metastasis (6 papers). Mitsuhiko Abe is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Cancer Cells and Metastasis (6 papers). Mitsuhiko Abe collaborates with scholars based in Japan, United States and Sweden. Mitsuhiko Abe's co-authors include Hideki Iwamoto, Takuji Torimura, Hironori Koga, Kayoko Hosaka, Sharon Lim, Tõru Nakamura, Yihai Cao, Takahiro Seki, Michio Sata and Takato Ueno and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Cell Metabolism.

In The Last Decade

Mitsuhiko Abe

30 papers receiving 897 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitsuhiko Abe Japan 16 425 324 189 170 143 30 905
So Mee Kwon South Korea 18 510 1.2× 337 1.0× 199 1.1× 113 0.7× 141 1.0× 29 892
Jack Leslie United Kingdom 17 396 0.9× 208 0.6× 184 1.0× 260 1.5× 203 1.4× 34 1.1k
Chiara Busletta Italy 9 356 0.8× 283 0.9× 226 1.2× 299 1.8× 297 2.1× 15 940
Kate Huang China 19 550 1.3× 365 1.1× 142 0.8× 109 0.6× 82 0.6× 42 900
Romain Riscal United States 9 492 1.2× 356 1.1× 192 1.0× 95 0.6× 40 0.3× 12 822
Eva Crosas‐Molist Spain 16 625 1.5× 224 0.7× 293 1.6× 183 1.1× 217 1.5× 22 1.2k
Angélique Gougèlet France 15 602 1.4× 348 1.1× 184 1.0× 102 0.6× 116 0.8× 23 976
Shamir Cassim France 14 407 1.0× 281 0.9× 149 0.8× 78 0.5× 72 0.5× 17 696
Miguel Murillo Spain 14 662 1.6× 151 0.5× 379 2.0× 114 0.7× 160 1.1× 16 1.1k
Taiji Yamazoe Japan 13 546 1.3× 231 0.7× 437 2.3× 115 0.7× 92 0.6× 26 1.0k

Countries citing papers authored by Mitsuhiko Abe

Since Specialization
Citations

This map shows the geographic impact of Mitsuhiko Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuhiko Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuhiko Abe more than expected).

Fields of papers citing papers by Mitsuhiko Abe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuhiko Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuhiko Abe. The network helps show where Mitsuhiko Abe may publish in the future.

Co-authorship network of co-authors of Mitsuhiko Abe

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuhiko Abe. A scholar is included among the top collaborators of Mitsuhiko Abe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuhiko Abe. Mitsuhiko Abe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arinaga‐Hino, Teruko, Mitsuhiko Abe, Tomoya Sano, et al.. (2020). Prednisolone-responsive primary sclerosing cholangitis with autoimmune hemolytic anemia: a case report and review of the literature. Clinical Journal of Gastroenterology. 14(1). 330–335. 4 indexed citations
2.
Sakaue, Takahiko, Hironori Koga, Hideki Iwamoto, et al.. (2019). Glycosylation of ascites-derived exosomal CD133: a potential prognostic biomarker in patients with advanced pancreatic cancer. Medical Molecular Morphology. 52(4). 198–208. 51 indexed citations
3.
Iwamoto, Hideki, Mitsuhiko Abe, Yunlong Yang, et al.. (2018). Cancer Lipid Metabolism Confers Antiangiogenic Drug Resistance. Cell Metabolism. 28(1). 104–117.e5. 236 indexed citations
4.
Koga, Hironori, Jun Akiba, Mitsuhiko Abe, et al.. (2017). Pancreatic Neuroendocrine Tumors and EMT Behavior Are Driven by the CSC Marker DCLK1. Molecular Cancer Research. 15(6). 744–752. 32 indexed citations
5.
Abe, Mitsuhiko, Takafumi Yoshida, Jun Akiba, et al.. (2017). STAT3 deficiency prevents hepatocarcinogenesis and promotes biliary proliferation in thioacetamide-induced liver injury. World Journal of Gastroenterology. 23(37). 6833–6844. 11 indexed citations
6.
Yoshida, Takafumi, Jun Akiba, Takanori Matsui, et al.. (2017). Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice. Digestive Diseases and Sciences. 62(6). 1527–1536. 20 indexed citations
7.
Torimura, Takuji, Hideki Iwamoto, Toru Nakamura, et al.. (2016). Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma. Neoplasia. 18(7). 413–424. 21 indexed citations
8.
Yang, Yunlong, Yin Zhang, Hideki Iwamoto, et al.. (2016). Discontinuation of anti-VEGF cancer therapy promotes metastasis through a liver revascularization mechanism. Nature Communications. 7(1). 12680–12680. 83 indexed citations
9.
Iwamoto, Hideki, Tõru Nakamura, Hironori Koga, et al.. (2015). Inhibition of hypoxia-inducible factor via upregulation of von Hippel-Lindau protein induces “angiogenic switch off” in a hepatoma mouse model. Molecular Therapy — Oncolytics. 2. 15020–15020. 8 indexed citations
10.
Koga, Hironori, Mitsuhiko Abe, Jun Akiba, et al.. (2015). High expression of the putative cancer stem cell marker, DCLK1, in rectal neuroendocrine tumors. Oncology Letters. 10(4). 2015–2020. 14 indexed citations
11.
Inoue, Kinya, Takuji Torimura, Tõru Nakamura, et al.. (2012). Vandetanib, an Inhibitor of VEGF Receptor-2 and EGF Receptor, Suppresses Tumor Development and Improves Prognosis of Liver Cancer in Mice. Clinical Cancer Research. 18(14). 3924–3933. 35 indexed citations
12.
Abe, Mitsuhiko, Hironori Koga, Takafumi Yoshida, et al.. (2012). Hepatitis C virus core protein upregulates the expression of vascular endothelial growth factor via the nuclear factor‐κB/hypoxia‐inducible factor‐1α axis under hypoxic conditions. Hepatology Research. 42(6). 591–600. 38 indexed citations
14.
Nakamura, Tõru, Takuji Torimura, Hideki Iwamoto, et al.. (2011). Prevention of liver fibrosis and liver reconstitution of DMN‐treated rat liver by transplanted EPCs. European Journal of Clinical Investigation. 42(7). 717–728. 21 indexed citations
15.
Iwamoto, Hideki, Takuji Torimura, Tõru Nakamura, et al.. (2011). Metronomic S-1 Chemotherapy and Vandetanib: An Efficacious and Nontoxic Treatment for Hepatocellular Carcinoma. Neoplasia. 13(3). 187–197. 27 indexed citations
16.
Yanagimoto, Chikatoshi, Masaru Harada, Hiroto Kumemura, et al.. (2011). Copper incorporation into ceruloplasmin is regulated by Niemann–Pick C1 protein. Hepatology Research. 41(5). 484–491. 26 indexed citations
17.
Nakamura, Tõru, Vı́ctor Tsutsumi, Takuji Torimura, et al.. (2011). Human peripheral blood CD34‐positive cells enhance therapeutic regeneration of chronically injured liver in nude rats. Journal of Cellular Physiology. 227(4). 1538–1552. 14 indexed citations
18.
Sakata, Masahiro, Takumi Kawaguchi, Eitaro Taniguchi, et al.. (2011). Quick and simple method for increasing the reduced albumin fraction in human serum albumin preparations by using stronger neo‐minophagen C. Hepatology Research. 41(11). 1120–1125. 4 indexed citations
19.
Kawaguchi, Takumi, Sho‐ichi Yamagishi, Minoru Itou, et al.. (2009). Pigment Epithelium-Derived Factor Inhibits Lysosomal Degradation of Bcl-xL and Apoptosis in HepG2 cells. American Journal Of Pathology. 176(1). 168–176. 22 indexed citations
20.
Kawaguchi, Takumi, Eitaro Taniguchi, Minoru Itou, et al.. (2009). Thrombocytopenia, an Important Interfering Factor of Antiviral Therapy and Hepatocellular Carcinoma Treatment for Chronic Liver Diseases. The Kurume Medical Journal. 56(1/2). 9–15. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026